Fatty acid hydroperoxide lyase (HPL) is a key enzyme in the biosynthesis of plant volatiles involved in defense responses to mechanical or herbivore-induced wounding. We report here the synthesis of imidazole derivatives and their inhibitory activities on the tomato 13-HPL subfamily. Among 11 newly synthesized compounds, we found that 1-[2-benzyloxy-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (3) exhibits inhibitory activity against recombinant 13-HPL with an IC 50 value of approximately 39 mM. Optical difference spectroscopy analysis of compound 3 and HPL interaction indicated that this compound induces a type II binding spectra with a K d value of approximately 13.5 mM.
Introduction
Phyto-oxylipins comprise a group of bioactive compounds that are biosynthesized from polyunsaturated fatty acids, such as linoleic acid and linolenic acid.
1) The initial step in the biosyntheses of most phyto-oxylipins is catalyzed by lipoxygenase (LOX), which adds molecular oxygen to either the C-9 or C-13 position of linolenic or linoleic acid.
2) The resulting hydroperoxides are further metabolized by several enzymes, including the following three closely related members of the CYP74 family of cytochrome P450s: hydroperoxide lyase (HPL), allene oxide synthase (AOS), and divinyl ether synthase (DES). 1) The products of these P450s are intermediates in the divergent biosynthetic pathway of acyclic or cyclic phyto-oxylipins.
Hydroperoxide lyases (HPL), ubiquitously found in the plant kingdom, catalyze the cleavage reaction of fatty acid hydroperoxides into volatile unsaturated aldehydes, alcohols and the corresponding oxo fatty acids.
3) Based on its substrate specificity, HPL is divided into two subfamilies, 13-HPL (CYP74B) and 9-/13-HPL (CYP74C). 4) The 13-HPL members preferentially cleave (S)-13-hydroperoxylenolenic acid or (S)-13-hydroperoxylenoleic acid into hexanal and (Z)-3-hexenal, respectively. These phytooxylipins, specifically the six-carbon alcohols, aldehydes and esters, are known as C 6 -volatiles. C 6 -Volatiles are important signaling molecules regulating plant defense responses. 3) They are present at trace levels in undamaged healthy plants, but are emitted in large quantities within seconds of mechanical or herbivore-induced wounding. 5) This emission occurs directly from the wounding site, but examples of induction and systemic release have also been reported. 6) Undamaged plants, when exposed to C 6 -volatiles, respond by inducing defense-related genes and secondary metabolites. 7) In addition, C 6 -volatiles possess fungicidal and bactericidal activity, 8) and are major contributors to the aroma of many fruits, vegetables, and green leaves.
9)
The importance of phyto-oxylipins in plant defenses has primarily focused on the jasmonate family of molecules generated by the AOS branch pathway. 10) In contrast, studies on the HPL branch are still scarce. Although observations clearly show that plants perceive and respond to C 6 -volatiles, little is known about the molecular mechanisms by which plants perceive, mediate and respond to these volatiles. As HPL is a key enzyme in the biosynthesis of C 6 -volatiles, a specific HPL inhibitor may be a useful tool for investigating the molecular mechanisms of C 6 -volatile action in plants. With this aim, we initiated a systemic search for inhibitors that target 13-HPL. Based on sequence homology and electron paramagnetic resonance spectra, 13-HPL was classified as a member of the cytochrome P450 family.
3) The catalytic and inhibitory mechanisms of P450s have been extensively elucidated. The inhibition mechanism of many P450s inhibitors is based on the coordination of the inhibitor to the ferric heme that forces the enzyme to change from the high-to low-spin form. This spin state change makes P450 reduction more difficult 11) and thereby interferes with P450
functions. Imidazole derivatives have found particularly widespread utility as P450s inhibitors, 12) apparently due to the intrinsic affinity of the nitrogen electron pair in heterocyclic molecules for the prosthetic heme iron. Thus, imidazole derivatives are potential candidates for 13-HPL inhibitors.
Miconazole, an imidazole type antifungal agent, 13) is widely used clinically and experimentally as a cytochrome P450 inhibitor. It is known that miconazole inhibits several steps that are catalyzed by an unspecific monooxygenase (EC:1.14.14.1) in arachidonic acid metabolism, 14) implying that miconazole may inhibit P450 enzymes in lenolenic acid metabolism, including Note 13-HPL. In order to verify this possibility, we tested the inhibitory activity of miconazole on 13-HPL. As a result, we found that miconazole inhibited HPL in our assay system with an IC 50 of approximately 65 mM. Consequently, we used miconazole as a lead compound and searched for more potent HPL inhibitors. We report herein the synthesis and biological evaluation of miconazole derivatives as inhibitors of 13-HPL.
Materials and Methods

General
Chemicals for synthesis were purchased from Acros Organic BVBA (Geel, Belgium), Kanto Chemicals Co. 
Chemical synthesis of imidazole derivatives
Compounds were prepared by a method described previously.
15)
To a stirred solution of 1-(2,4-dichlorophenyl)-2-imidazol-1-ylethanol (Acros Organic BVBA (Geel, Belgium)) (1) 
Preparation of (9Z,11E,13S,15Z)-13-hydroperoxyoctadeca-9,11,15-trienoic acid ((13S)-HPOT)
(13S)-HPOT was prepared from linolenic acid as described previously.
15) (13S)-HPOT was dissolved in methanol and stored at Ϫ80°C.
Expression and purification of recombinant tomato HPL
A region of the LeHPL cDNA from the EcoRI site just downstream of the initiation codon to the HindIII site 30 bp downstream of the stop codon was inserted into the corresponding site of the E. coli expression vector, pQE31(QIAGEN), and used to transform competent M15 bacteria. Expression and purification of HPL was carried out as described previously. 16) 
Measurement of HPL activity
HPL activity was recorded with a Shimadzu UV-3100 spectrophotometer (Kyoto, Japan) essentially as previously described. 16) Briefly, stock solutions of test compounds in DMSO (100 mM to 10 mM) were stored at Ϫ20°C before use. In a 1-cm path cuvette, 3 ml of 50 mM sodium phosphate buffer (pHϭ7.0) containing 0.1% Tween 20 (Aldrich) was mixed with (13S )-HPOT substrate (6 mM). The stock solution of test compounds was added (less than 0.1%) to make a given concentration of test compounds at 25°C. The reaction was started by adding 1 pmol purified HPL. Activity was measured by following the decrease in absorption at 235 nm. The initial velocity of the decrease was followed for 1 min. Metabolism of (13S )-HPOT was calculated according to Lambert Beer's Law (eϭ24315).
17)
Binding of compound 3 to recombinant HPL
Binding of compound 3 to HPL was measured by optical difference spectroscopy of purified recombinant HPL using a Shimadzu UV3100 spectrophotometer as described previously. 16) Purified recombinant HPL was diluted in 50 mM sodium phosphate buffer (pHϭ7.0) with 0.1% Tween 20 to a final concentration of 1.5 mM together with 20% glycerol and split into two matched black-walled quartz cuvettes (1 ml). After running a baseline, 1 mL of compound 3 (5 mM dissolved in DMSO) was added to the sample cuvette, and an equal volume of DMSO was added to the reference cuvette. The samples were equilibrated for 2 min, and the difference spectrum was then run between 380 and 500 nm. The final addition volume was kept to Ͻ1% of the total volume. Changes in absorbance as a function of compound 3 concentration (5, 8, 10 , 20, 30, 40, 50 mM), at wavelengths selected on the basis of the spectral characteristics of the individual sample, were used to calculate binding constants based on linear regression analysis. Spectral determinations were performed at least twice for each experiment and were found to be reproducible with respect to the spectral profile and the positions of l max and l min .
Results and Discussion
Chemical modification of miconazole was carried out using commercially available 1-(2,4-dichlorophenyl)-2-imidazol-1-ylethanol (1) as a starting material (scheme 1). All compounds showed a single spot by thin-layer chromatography and an appropriate 1 H NMR spectrum and elementary analysis. Table 1 shows the inhibitory activity of synthesized compounds to 13-HPL. We used miconazole as a standard for structure-activity relationship studies. Introduction of a benzyl substitution to the 1-(2, 4-dichlorophenyl)-2-imidazol-1-ylethanol (3) enhanced 13-HPL inhibition with an IC 50 of approximately 39 mM. Introduction of mono-substitution of chlorine to the phenyl or pyridine ring (4-6) significantly reduced the potency of 13-HPL inhibition. Introduction of two chlorines to the phenyl ring at position 2 and 6 (8) and at positions 3 and 4 (9) also reduced inhibitory activity against 13-HPL, while compound 7 with two chlorines at positions 2 and 3 exhibited inhibitory activity against 13-HPL with an IC 50 value of approximately 46 mM. Introduction of two strong electron withdraw groups of fluorine to the phenyl ring also reduced 13-HPL inhibitory activity (10) (11) (12) (13) . Although limited compounds were synthesized and tested for 13-HPL inhibition in the present work, comparing the biological activities of 13-HPL inhibition and antifungal activity of these compounds suggested further investigations. First, miconazole and its derivatives are potent antifungal agents 14) and the structure-activity relationship (SAR) studies indicated that the elecScheme 1. Synthesis of compounds of general structure.
tron withdrawing substituents on the phenyl ring of benzyloxy group are effective. In contrast, data obtained in the present work indicate that fluorine substituents derivatives (10-13) did not enhance the potency of 13-HPL inhibition, implying that structure requirements for these two activities may be different. Secondly, SAR studies on the effect of electron-donating substituents of this synthetic series should be determined further. Nevertheless, the compounds reported in this study are the first example of synthetic chemicals that inhibit 13-HPL, and compound 3 is the most potent inhibitor of 13-HPL reported to date. In order to further determine the binding of imidazoles to 13-HPL, we measured the optical difference spectra upon addition of compound 3 to recombinant 13-HPL by a method described previously.
15) The addition of compound 3 to the 13-HPL protein induced a type II absorbance shift of the heme Soret band from 419 to 423 nm, characteristic of the change from a low to high spin state of the ferric iron that is usually associated with direct coordination of the imidazole group of compound 3 to the heme iron of 13-HPL ( Fig. 2A) . The dissociation constant K d was determined by titrating the observed spectral absorbance difference DA (428-391 nm) versus the concentration of the inhibitor (Fig.  2B) . The K d of compound 3 was approximately 13.5 mM. These results indicate that the inhibition of 13-HPL activity by compound 3 is based on the coordination of the inhibitor to the ferric heme. It has been reported that HPL is significantly inhibited by the lipophilic antioxidant, nordihydroguaiaretic acid (NDGA), with an IC 50 of approximately 50 mM. 18) NDGA is known as a radical scavenger, and is thought to inhibit HPL by its ability to trap alkoxyl radicals, which are intermediates in the catalytic action of HPL. In contrast, the mechanism of imidazole in P450 inhibition is based on the coordination of the inhibitor to the ferric heme. It appears, therefore, that these two classes of inhibitors have different modes of action in HPL inhibition. We have identified the lead compound for HPL inhibitors, and the methodology for the preparation of imidazole derivatives has been studied in considerable detail. 19) We therefore expect that further development of imidazole derivatives will lead to the discovery of potent specific inhibitors of HPL. B) The spectral dissociation constant was calculated from a double reciprocal plot of absorbance differences, DA (428-391 nm) versus compound 3 concentrations gave 13.5 mM. 
